LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
Company nameLeMaitre Vascular Inc
IPO dateOct 19, 2006
CEOLemaitre (George W)
Number of employees651
Security typeOrdinary Share
Fiscal year-endOct 19
Address63 2nd Ave
CityBURLINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01803
Phone17812212266
Websitehttps://www.lemaitre.com/
Ticker SymbolLMAT
IPO dateOct 19, 2006
CEOLemaitre (George W)